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Abstract
Background: Myristica fragrans Houtt. (nutmeg) has been mentioned in Unani medicine to be of
value in the management of male sexual disorders. The present study was undertaken to evaluate
the aphrodisiac effect of 50% ethanolic extract of nutmeg along with its likely adverse effects and
acute toxicity using various animal models.
Methods: The suspension of the extract was administered (100, 250 and 500 mg/kg, p.o.) to
different groups of male rats daily for seven days. The female rats involved in mating were made
receptive by hormonal treatment. The general mating behaviour, libido and potency were studied
and compared with the standard reference drug sildenafil citrate. Likely adverse effects and acute
toxicity of the extract were also evaluated.
Results: Oral administration of the extract at the dose of 500 mg/kg, produced significant
augmentation of sexual activity in male rats. It significantly increased the Mounting Frequency,
Intromission Frequency, Intromission Latency and caused significant reduction in the Mounting
Latency and Post Ejaculatory Interval. It also significantly increased Mounting Frequency with penile
anaesthetisation as well as Erections, Quick Flips, Long Flips and the aggregate of penile reflexes
with penile stimulation. The extract was also observed to be devoid of any adverse effects and
acute toxicity.
Conclusion: The resultant significant and sustained increase in the sexual activity of normal male
rats without any conspicuous adverse effects indicates that the 50% ethanolic extract of nutmeg
possesses aphrodisiac activity, increasing both libido and potency, which might be attributed to its
nervous stimulating property. The present study thus provides a scientific rationale for the
traditional use of nutmeg in the management of male sexual disorders.
Background
Nutmeg is the dried kernel of broadly ovoid seed of Myr-
istica fragrans Houtt. (Myristicaceae), a bushy evergreen
tree 10–20 m high, indigenous to India, Indonesia and
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tries of both the hemispheres [3]. M. fragrans commonly
known as nutmeg is widely used as spice and in alterna-
tive medicine it has been reported to have aphrodisiac
[4,5], stomachic, carminative [6], tonic [7], nervous stim-
ulant [8], aromatic, narcotic, astringent, hypolipidemic,
antithrombotic, antifungal, antidysentric and anti inflam-
matory properties [9]. It is reported to be useful in paraly-
sis [10] and increases blood circulation [11]. It has also
been reported to have antioxidant property [12]. Phyto-
chemical studies indicate that nutmeg contains a volatile
oil, a fixed oil, proteins, fats, starch and mucilage. The
fixed oil contains myristin and myristic acid. Nutmeg
yields 5–15% of volatile oil, which contains pinene, sab-
inene, camphene, myristicin, elemicin, isoelemicin, euge-
nol, isoeugenol, methoxyeugenol, safrole, dimeric
phenylpropanoids, lignas and neolignas [1,13,14] and by
expression it yields a product known as nutmeg butter.
Eugenol the major constituent inhibits lipid peroxidation
and maintains activities of enzymes like superoxide dis-
mutase, catalase, glutathione peroxidase, glutamine trans-
ferase and glucose-6-phosphate dehydrogenase [15], and
has also been reported to have vasodilatory [16] and
smooth muscle relaxant property [17]. There is no infor-
mation regarding the chemical constituents in 50% eth-
anolic extract of nutmeg, but their amount in the extract
seems to be lower than in nutmeg. However, its prelimi-
nary phytochemical studies that were performed as
described by Jenkins et al. [18] indicate the presence of
sterols, phenols, alkaloids and. Amino acids. The chloro-
form extract of nutmeg showed analgesic and anti-inflam-
matory activity in rodents [19], and also exhibited
antidiarrheal activity by increasing tissue contents of Na+
and Cl- ions [20]. The petroleum ether extract of M. fra-
grans fruits possesses anti-diarrheal property [21], and its
n-hexane extract has been reported to have memory
enhancing effect in mice [22]. The ethanolic extract (50%)
of nutmeg exhibited significant aphrodisiac effect in male
mice in our earlier study, in which only mounting fre-
quency and mating performance were considered as the
markers for sexual function [23].
Considering above information, nutmeg-extract (50%
ethanolic) was subjected to a detailed screening for sexual
function improving activity using various animal models.
The standard drug sildenafil citrate was used as a referent
for quantitative comparison. Likely treatment-related
adverse effects and acute toxicity were also evaluated. The
doses used in the study were selected according to
Freirich[24], multiplying the Unani clinical doses
[10,25,26] by the conversion factor of 7.
Methods
Plant material
Dried kernel of M. fragrans (nutmeg) was procured from
the market (Delhi, India). The plant material was authen-
ticated by Prof. S. H. Afaq, In-charge, Pharmacognosy Sec-
tion, Department of Ilmul Advia, Faculty of Unani
Medicine, Aligarh Muslim University, Aligarh, India. A
voucher (M144) sample was deposited for further
reference.
Extraction procedure
Nutmeg was crushed to coarse powder and sieved through
No. 20–40 mesh sieve and refluxed by mixing the pow-
dered nutmeg with 1:3 w/v in 50% ethanol v/v by Soxhlet
apparatus for 6 h. The extract was filtred and the solvent
from the filtrate was removed by rotary evaporator under
reduced pressure and low temperature. The yield of extract
was 21.20% w/w in terms of dried starting material. The
extract was preserved in a refrigerator.
Chemicals
Sildenafil citrate was obtained from Zydus Cadila
(Ahmadabad, India). Ethinyl oestradiol was a gift from
Infar Limited (Kolkata, India). Progestereon was procured
from Sun Pharmaceutical Industries Limited (Mumbai,
India) and 5% xylocaine ointment was obtained from
Astra IDL Limited (Bangalore, India).
Animals
Three month old male and female albino rats of Wistar
strain weighing 350–400 g and 225–275 g, respectively,
were used for aphrodisiac study. Adult albino mice of
either sex weighing 25–35 g were used for acute toxicity
testing. All the animals were housed singly in separate
standard propylene cages and maintained under standard
laboratory conditions (temperature 24–28°C, relative
humidity 60–70%, 12 h light-dark cycle) with water and
food (Gold Mohar, Lipton-India) ad libitum. The Depart-
mental ethical committee for animal care and use
approved the experimental design.
Drug preparation
Nutmeg in Unani medicine is orally administered, there-
fore the extract was suspended in distilled water using
Tween-80 (1%) for oral administration. Similarly sildena-
fil citrate and ethinyl oestradiol were also suspended in
distilled water using Tween -80 (1%) separately, for oral
use. Progesterone was dissolved in olive oil for subcutane-
ous injection. All the drug solutions were prepared just
before administration.
Mating behaviour test
The effect of the test drug on mating behaviour was stud-
ied according to the methods described by Dewsbury and
Davis Jr. [27] and Szechtman et al. [28], modified by us.Page 2 of 7
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for the study. They were divided in to five groups each
consisting of six rats and placed individually in separate
propylene cages during the experiment. Group 1 served as
control group and received 10 ml/kg of distilled water
orally, daily for 7 days at 18:00 h. Groups 2–4 received
suspension of the extract orally at the doses of 100, 250
and 500 mg/kg, respectively, once a day for 7 days at
18:00 h. Group 5 served as standard group and given sus-
pension of the standard drug 1 h before the commence-
ment of the experiment. Since the male animals should
not be tested in unfamiliar circumstances the animals
were brought to the laboratory and exposed to dim light
(in 1 w fluorescent tube in a laboratory of 14' × 14') at the
stipulated time of testing daily for 6 days before the
experiment.
The female rats allow mating only during the estrus phase.
Thus, they were artificially brought into oestrus (heat) by
the method of Szechtman et al [28]. They were adminis-
tered suspension of ethinyl oestradiol orally at the dose of
100 µg/animal 48 h prior to the pairing plus progesterone
injected subcutaneously, at the dose of 1 mg/animal 6 h
before the experiment. The receptivity of the female ani-
mals was confirmed before the test by exposing them to
male animals, other than the control, test and standard
animals. The most receptive females were selected for the
study. The experiment was carried out on the 7th day after
commencement of the treatment of the male animals. The
experiment was conducted at 20:00 h in the same labora-
tory and under the light of same intensity. The receptive
female animals were introduced into the cages of male
animals with 1 female to 1 male. The observation for mat-
ing behaviour was immediately commenced and contin-
ued for first 2 mating series. The test was terminated if the
male failed to evince sexual interest. If the female did not
show receptivity it was replaced by another artificially
warmed female. The occurrence of events and phases of
mating were called out to be recorded on an audio-cas-
sette as soon as they appeared. Their disappearance was
also called out and recorded. Later, the frequencies and
phases were determined from cassette transcriptions:
number of mounts before ejaculation or Mounting Fre-
quency (MF), number of intromission before ejaculation
or Intromission Frequency (IF), time from the introduc-
tion of female into the cage of the male upto the first
mount or Mounting Latency (ML), time from the intro-
duction of the female up to the first intromission by the
male or Intromission Latency (IL), time from the first
intromission of a series upto the ejaculation or Ejacula-
tory Latency (EL), and time from the first ejaculation upto
the next intromission by the male or Post Ejaculatory
Interval (PEI). In the second mating series only the EL was
recorded. The values for the observed parameters of the
control, test and standard animals were statistically ana-
lysed by using one-way analysis of variance (ANOVA)
method.
Test for libido
The test was carried out by the method of Davidson [29],
modified by us. Sexually experienced male rats were
divided into five groups each consisting of six rats and
kept singly in separate propylene cages during the experi-
ment. Group 1 represented the control group, which
received 10 ml/kg of distilled water orally, once a day for
7 days at 18:00 h. Group 2–4 received suspension of the
extract orally at the doses of 100, 250 and 500 mg/kg,
respectively, daily for 7 days at 18:00 h. Group 5 served as
standard group and given suspension of the standard drug
orally at the dose of 5 mg/kg, 1 h prior to the commence-
ment of the experiment. The female rats were made recep-
tive by hormonal treatment and all the animals were
accustomed to the testing condition as previously men-
tioned in mating behaviour test. The animals were
observed for Mounting Frequency (MF) on the evening of
7th day at 20:00 h. The penis was exposed by retracting the
sheath and 5% xylocaine ointment was applied 30, 15
and 5 min before starting observations. Each animal was
placed individually in a cage and the receptive female rat
was placed in the same cage. The number of mountings
was noted. The animals were also observed for intromis-
sion and ejaculation. The MF in control, test and standard
animals was statistically analysed by employing one-way
analysis of variance (ANOVA) method.
Test for potency
The test was carried out by the methods of Hart and Hau-
gen [30] and Hart [31], modified by us. The male rats were
divided in to five groups each consisting of six rats and
placed individually in separate propylene cages during the
experiment. Group 1 represented the control group,
which received 10 ml/kg of distilled water orally daily for
7 days. Group 2–4 received suspension of the test drug
orally at the dose of 100, 250 and 500 mg/kg, respectively,
daily for 7 days. Group 5 served as standard group and
received suspension of the standard drug orally at the dose
of 5 mg/kg, 1 h prior to the commencement of the exper-
iment. On the 8th day, the test for penile reflexes was car-
ried out by placing the rat on its back, in a glass cylinder
for partial restraint. The preputial sheath was pushed
behind the glans by means of thumb and index finger and
held in this manner for a period of 15 min. Such stimula-
tion elicits a cluster of genital reflexes. The following com-
ponents were recorded: Erections (E), Quick Flips (QF)
and Long Flips (LF). The frequency of these parameters
observed in control, test and standard groups was statisti-
cally analysed by using one-way analysis of variance
(ANOVA) method.Page 3 of 7
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All treated rats were observed at least once daily for any
overt sign of toxicity (salivation, rhinorrhoea, lachryma-
tion, ptosis, writhing, convulsions and tremors), stress
(erection of fur and exophthalmia) and changes in behav-
iour (such as spontaneous movement in the cage, climb-
ing, cleaning of face). In addition, food and water intake
was noted.
Acute toxicity testing
The acute toxicity of the extract was studied in adult
albino mice of either sex. They were divided into five
groups each consisting of six mice. The suspension of the
extract was administered orally at four different doses of
500, 1000, 2000 and 4000 mg/kg, respectively, to differ-
ent groups of mice separately. Control animals received
10 ml/kg of distilled water orally. The animals were
observed continuously for the initial 4 h for behavioural
changes and mortality and intermittently for the next 6 h
and then again at 24 h and 48 h after dosing. The behav-
iour parameters observed were convulsion, hyperactivity,
sedation, grooming, loss of righting reflex and increased
respiration.
Statistical analysis
The significance of difference between the means was
determined by one-way analysis of variance (ANOVA)
with post-hoc't' test. P value <0.05 was considered as
significant.
Results
Effect of the extract on mating behaviour
The results of mating behaviour test show that the extract
at the dose of 500 mg/kg, significantly increased the
Mounting Frequency (MF) (P < 0.001), Intromission Fre-
quency (IF) (P < 0.001), Ejaculatory Latency in first series
(EL1) (P < 0.001), Ejaculatory Latency in second series
(EL2) (P < 0.001), and caused significant reduction in the
Mounting Latency (ML) (P < 0.001), Intromission Latency
(IL) (P < 0.01) and Post Ejaculatory Interval (PEI) (P <
0.001), as compared to control group. The dose of 250
mg/kg of the extract significantly increased the MF(P <
0.001), IF (P < 0.01) and significantly decreased the ML (P
< 0.01), PEI (P < 0.001), IL (P < 0.05), EL1 (P < 0.05) and
did not significantly alter the EL2, in comparison with the
control group. Whereas, the extract at the dose of 100 mg/
kg, significantly increased the MF (P < 0.01) and PEI(P <
0.05), but did not affect the IF, ML, IL, EL1 and EL2 in a sig-
nificant manner as compared to control group. However,
the standard drug increased the MF (P < 0.001), IF (P <
0.001), EL1 (P < 0.001), EL2 (P < 0.001) and PEI (P <
0.001) as well as decreased the ML (P < 0.001) and IL (P
< 0.001) in a highly significant manner as compared to
control animals (Table 1).
Effect of the extract on libido
The results obtained with the test for libido show that the
extract at the dose of 500,250 and 100 mg/kg, signifi-
cantly increased the Mounting Frequency (MF) (P <
0.001, P < 0.01 and P < 0.05, respectively) as compared to
control group. The standard drug also significantly
increased the MF (P < 0.001) as compared to control ani-
mals. Intromission and Ejaculation were absent in con-
trol, test and standard groups (Table 2).
Effect of the extract on potency
The test for potency revealed that the extract at the dose of
500 mg/kg, significantly increased the frequency of Erec-
tions (E) (P < 0.001), Quick Flips (QF) (P < 0.001) and
Long Flips (LF) (P < 0.001) as well as the aggregate of
these penile reflexes (TPR) (P < 0.001) in comparison
with the control group. The test drug at the dose of 250
mg/kg, significantly increased the E (P < 0.05), LF (P <
0.01) and TPR (P < 0.05) but did not significantly affect
Table 1: Effect of 50% ethanolic extract of M. fragrans (nutmeg) on mating behaviour in male rats











Mounting Frequency (MF) 11.50 ± 1.22 14.3 ± 0.49** 23.70 ± 1.47*** 43.80 ± 0.94*** 48.70 ± 2.34***
Intromission Frequency (IF) 5.50 ± 1.22 5.50 ± 0.42 NS 8.17 ± 0.60** 12.50 ± 0.76*** 24.70 ± 0.81***
Mounting Latency (ML, in sec) 35.30 ± 1.51 35.80 ± 1.46 NS 28.50 ± 0.34** 22.80 ± 0.87*** 11.70 ± 1.37***
Intromission Latency (IL, in sec) 40.00 ± 5.29 37.70 ± 1.97 NS 34.00 ± 1.65* 27.50 ± 1.80** 15.00 ± 0.89***
Ejaculatory Latency in first series (EL1, in sec) 198.00 ± 0.98 211.00 ± 6.69 NS 218.00 ± 2.13* 235.00 ± 6.65*** 344.50 ± 12.00***
Ejaculatory Latency in second series (EL2, in sec) 297.33 ± 8.10 300.00 ± 4.98 NS 319.00 ± 6.98 NS 358.00 ± 7.22*** 398.16 ± 13.50***
Post Ejaculatory Interval (PEI, in sec) 364.00 ± 12.22 336.00 ± 7.92* 301.00 ± 6.89*** 224.00 ± 4.69*** 99.00 ± 5.68***
Tabular values are mean ± SEM, n = 6 (number of animals in each group); significant difference from control, NS: Not significant. *P < 0.05, **P < 
0.01; ***P < 0.001.Page 4 of 7
(page number not for citation purposes)
BMC Complementary and Alternative Medicine 2005, 5:16 http://www.biomedcentral.com/1472-6882/5/16the QF. Whereas, the extract at the dose of 100 mg/kg, did
not alter the E, QF, LF and TPR. The standard drug also sig-
nificantly increased the E (P < 0.001), QF (P < 0.001), LF
(P < 0.001) and TPR (P < 0.001) with respect to the con-
trol animals (Table 3).
Adverse effects
No treatment-related overt signs of toxicity, stress and
changes in behaviour were observed. The food and water
intake of all the treated animals remained similar to those
of the control group.
Acute toxicity studies
No mortality and changes in the behaviour were observed
in all the treated and control groups of mice up to a dose
of 4000 mg/kg.
Discussion
The present study was aimed to investigate the aphrodis-
iac effect of nutmeg extract (50% ethanolic) along with its
acute toxicity using various animal models. The study
exhibits a marked change in sexual behaviour of male rats.
The results of the present investigations show that the test
drug significantly increased the Mounting Frequency
(MF) and Intromission Frequency (IF) as compared to
control group. However, the standard drug produced a
greater increase in thse parameters. The MF and IF are con-
sidered the indices of both libido and potency. Thus, the
increase in the MF and IF, indicates that nutmeg, along
with increasing libido, probably also increases the
potency. The significant increase in the Ejaculatory
Latency (EL) suggests that the extract and standard drug
prolonged the duration of coitus. The significant increase
in the EL in both first and second series as well as the
decrease in the Post Ejaculatory Interval (PEI), i.e. the
refractory period between first and second series of mat-
ing, suggest that the test drug intensified sexual activity in
a sustained manner. The test drug also caused a significant
reduction in the Mounting Latency (ML) and Intromis-
sion Latency (IL) as compared to control animals, while a
highly significant decrease was observed in the ML of ani-
mals treated with the referent drug. This also provides an
evidence for aphrodisiac effect of the test drug. These find-
ings show that the test drug produces a striking enhance-
ment of over-all sexual performance of normal animals.
MF after penile anesthetization of rats is a reliable index of
'pure' libido and the penile reflexes of the rats are a good
model of 'pure' potency [29]. Therefore, in the present
study the extract was also studied for effect on these com-
ponents of sexual behaviour.
The effect of the test drug on libido was studied by assess-
ing the MF after genital anaesthetization which does away
Table 2: Effect of 50% ethanolic extract of M. fragrans (nutmeg) on mounting frequency (test for libido) in male rats











Mounting Frequency (MF) 6.17 ± 0.98 7.83 ± 0.47* 8.50 ± 0.56** 14.50 ± 4.43*** 23.00 ± 2.17***
Intromission Frequency (IF) Nil Nil Nil Nil Nil
Ejaculation (EJ) Absent Absent Absent Absent Absent
Tabular values are mean ± SEM, n = 6 (number of animals in each group); significant difference from control, *P < 0.05, **P < 0.01; ***P < 0.001.
Table 3: Effect of 50% ethanolic extract of M. fragrans (nutmeg) on penile reflexes (test for potency) in male rats>











Erections (E) 7.67 ± 1.63 7.50 ± 0.42 NS 8.00 ± 0.36* 12.66 ± 0.75*** 19.00 ± 2.64***
Quick Flips (QF) 5.17 ± 0.75 5.50 ± 0.49 NS 5.83 ± 0.56 NS 8.66 ± 0.36*** 17.30 ± 4.13***
Long Flips (LF) 2.17 ± 1.17 3.33 ± 0.30 NS 4.50 ± 0.42** 8.50 ± 0.42*** 12.00 ± 2.26***
Total Penile Reflexes (TPR) 15.01 ± 3.55 16.33 ± 1.21 NS 18.33 ± 1.34* 29.82 ± 1.53*** 48.30 ± 9.03***
Tabular values are mean ± SEM, n = 6 (number of animals in each group); significant difference from control, NS: Not significant. *P < 0.05, **P < 
0.01; ***P < 0.001.Page 5 of 7
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ing the study of pure libido or intrinsic sexual desire. Dur-
ing the experiment the test drug produced a significant
increase in the MF of sexually normal male rats. Whereas,
the MF was much reduced in control, test and standard
animals in comparison with the MF of corresponding
groups in mating behaviour test where the penis had not
been anaesthetized. However, the test for libido revealed
that Intromission and Ejaculation were absent in all
groups of animals, as the genital sensations which are
absent due to penile anaesthetization are necessary for the
development of these two events. Thus, it may be inferred
that the test drug produced a striking increase in 'pure'
libido.
The test for potency exhibited that the extract significantly
increased the frequency of all the components of penile
reflexes: Erections (E), Quick Flips (QF) and Long Flips
(LF) as compared to control group, but comparatively less
than the standard drug. The aggregate of these penile
reflexes (TPR) was also significantly increased in both test
and standard animals. This indicates that the test drug
increases 'pure'potency also.
Although the effect of the extract on 'pure' libido and
'pure' potency was evaluated by using two different meth-
ods, a rough comparison of the results indicates that the
test drug augmented both libido and to an equal extent
potency. The positive inferences from the specific tests for
libido and potency substantiate the indications of the
mating behaviour test to show in a rather conclusive man-
ner that the test drug enhances both the libido and
potency in normal male animals. These conclusions are
further supported by an earlier study reporting libido and
potency increasing effect of nutmeg in mice[23].
In addition, nutmeg, a well know spice and a herbal drug
is widely used in Unani medicine without any known or
recorded toxicity in the management of male sexual disor-
ders. Such herbal drugs may be directly used, without any
toxicity testing. However, when an extract or active frac-
tion of such drug is used it is better to evaluate possible
toxicity. Although it is the normal practice to determine
the LD50 value, now it is acceptable to limit the study to an
acute toxicity test using multiple doses including reasona-
bly high doses of the drug [32].
In this connection the test drug was also subjected to an
acute toxicity testing and it was tested up to a high concen-
tration of 4000 mg/kg, orally (eight times more than the
aphrodisiac dose, evaluated in the present study). Even at
this dose the extract did not produce signs of toxicity or
treatment- related adverse effects in the tests for aphrodis-
iac activity. This suggests that its short term use for this
purpose is apparently safe.
With regard to the mechanism of the test drug, it is diffi-
cult to explain the exact mechanism responsible for
improving sexual function. The drug induced changes in
neurotransmitter level or their action at cellular level
could change sexual behaviour [33]. Nutmeg is men-
tioned in ethnomedical literature as nervous stimulant
[8]. The extract (50% ethanolic) of nutmeg is also
reported to have nervous stimulant action in male albino
rats [34]. Thus, the resultant aphrodisiac activity of the test
drug might be attributed to its nervous stimulating prop-
erty. Preliminary phytochemical studies indicate the pres-
ence of sterols, phenols, alkaloids and amino acids in the
extract. Hence, the sexual function improving effect of the
test drug might be due to the presence of such com-
pounds. Moreover, nutmeg, merits further studies for
detailed sexual function improving activities, especially at
higher doses. In addition, further research is also needed
for the identification of its active constituent (s) responsi-
ble for sexual function improving activities and the mech-
anism by which it augments sexual function.
Conclusion
The resultant significant and sustained increase in the sex-
ual activity of male rats, with out any conspicuous adverse
effects and toxicity, suggests that nutmeg possesses clini-
cally applicable aphrodisiac activity, and also lends sup-
port to the claims for its traditional usage as sexual
function enhancing medicine. Further, the study also indi-
cates that the aphrodisiac effects of the test drug may be
due to its nervous stimulating property. Thus, it may
prove to be an effective and safe alternative remedy in sex-
ual disorders.
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